5.835
Schlusskurs vom Vortag:
$5.93
Offen:
$5.97
24-Stunden-Volumen:
672.36K
Relative Volume:
0.36
Marktkapitalisierung:
$2.27B
Einnahmen:
$1.21B
Nettoeinkommen (Verlust:
$-95.29M
KGV:
-22.44
EPS:
-0.26
Netto-Cashflow:
$35.06M
1W Leistung:
-1.77%
1M Leistung:
-10.92%
6M Leistung:
-20.50%
1J Leistung:
+0.60%
Lifestance Health Group Inc Stock (LFST) Company Profile
Firmenname
Lifestance Health Group Inc
Sektor
Branche
Telefon
602-767-2100
Adresse
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Vergleichen Sie LFST mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
LFST
Lifestance Health Group Inc
|
5.835 | 2.30B | 1.21B | -95.29M | 35.06M | -0.26 |
![]()
HCA
Hca Healthcare Inc
|
384.34 | 91.09B | 71.59B | 5.78B | 4.95B | 22.49 |
![]()
THC
Tenet Healthcare Corp
|
171.46 | 15.44B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
EHC
Encompass Health Corp
|
121.54 | 12.10B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
189.39 | 12.31B | 16.08B | 1.20B | 1.06B | 17.82 |
![]()
DVA
Davita Inc
|
137.90 | 10.30B | 12.82B | 936.34M | 1.47B | 10.74 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-27 | Hochstufung | UBS | Neutral → Buy |
2025-04-08 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2025-04-03 | Eingeleitet | Canaccord Genuity | Buy |
2024-12-16 | Hochstufung | Goldman | Neutral → Buy |
2024-01-03 | Eingeleitet | Barclays | Underweight |
2023-05-15 | Herabstufung | TD Cowen | Outperform → Market Perform |
2023-01-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2022-11-07 | Fortgesetzt | Jefferies | Buy |
2022-03-17 | Herabstufung | UBS | Buy → Neutral |
2021-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
2021-09-10 | Eingeleitet | Cowen | Outperform |
2021-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-07-06 | Eingeleitet | Goldman | Neutral |
2021-07-06 | Eingeleitet | JP Morgan | Overweight |
2021-07-06 | Eingeleitet | Jefferies | Buy |
2021-07-06 | Eingeleitet | Morgan Stanley | Overweight |
2021-07-06 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lifestance Health Group Inc Aktie (LFST) Neueste Nachrichten
LifeStance Health Group, Inc. Elects Eric Palmer to Serve on its Board of Directors as Member of Class I, Effective June 3, 2025 - marketscreener.com
LifeStance Health Holds Annual Stockholders Meeting - TipRanks
lifestance health group announces results of annual shareholder meeting By Investing.com - Investing.com UK
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet - Nasdaq
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies LifeStance Health Group, Inc. (LFST) Investors of Class Action and to Actively Participate - ACCESS Newswire
LifeStance Health spikes as UBS upgrades on valuation - MSN
May 2025's Top Growth Stocks With Insider Confidence - simplywall.st
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference - GlobeNewswire
UBS Sees Misunderstood Strength in Lifestance Health Group (LFST), Upgrades to Buy - Insider Monkey
LifeStance Health Group (NASDAQ:LFST) Upgraded by UBS Group to “Buy” Rating - Defense World
Lifestance Health Bets On Cash Incentives For Big Savings - Finimize
LifeStance Health (LFST) Gets UBS Upgrade Amid Stock Rebound Pot - GuruFocus
LifeStance Health stock spikes as UBS upgrades (LFST:NASDAQ) - Seeking Alpha
“50% Upside” Possible for Lifestance Health Stock (NASDAQ:LFST), Shares Surge - TipRanks
Lifestance Health's Shift to Cash Incentives Could Save $40 Million Annually, UBS Says - marketscreener.com
Light & Wonder, Rocket Lab, AMC Entertainment, LifeStance Health Group, and Xerox Stocks Trade Up, What You Need To Know - Yahoo Finance
UBS Upgrades Lifestance Health Group to Buy From Neutral, $8.50 Price Target - marketscreener.com
(LFST) Long Term Investment Analysis - news.stocktradersdaily.com
LifeStance Health (LFST) Upgraded to Buy by UBS | LFST Stock New - GuruFocus
LifeStance Health (LFST) Upgraded to Buy by UBS | LFST Stock News - GuruFocus
This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Why LifeStance Health Group Shares Are Struggling - TipRanks
LifeStance (LFST) Receives Upgrade Amid Misunderstood Market Sig - GuruFocus
LifeStance (LFST) Receives Upgrade Amid Misunderstood Market Signals | LFST Stock News - GuruFocus
Q1 Earnings Highlights: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
3 Stocks Under $10 Skating on Thin Ice - Yahoo Finance
LifeStance Health names Vaughn Paunovich as CTO - MSN
LifeStance Health appoints new chief technology officer By Investing.com - Investing.com South Africa
LifeStance Health Group Appoints New Chief Technology Officer - TipRanks
LifeStance Health appoints new chief technology officer - Investing.com
LifeStance Names Vaughn Paunovich as Chief Technology Officer - marketscreener.com
LifeStance Health Announces Executive Changes - marketscreener.com
LifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2025 Earnings Call Transcript - Insider Monkey
LifeStance Health Exceeds Q1 2025 Expectations - TipRanks
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround - MSN
Earnings call transcript: LifeStance Health’s Q1 2025 results show growth and stock rise - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of LifeStance Health Group, Inc. (LFST) Investigation - ACCESS Newswire
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why - Yahoo Finance
LifeStance Health Reports Strong Q1 2025 Results - TipRanks
LifeStance Health Q1 2025 presentation: revenue up 11%, achieves positive net income - Investing.com Canada
LifeStance Health Group Q1 2025 Earnings Call Transcript - MarketBeat
LifeStance Health Q1 2025 presentation: revenue up 11%, achieves positive net income By Investing.com - Investing.com South Africa
LifeStance Health Group, Inc. SEC 10-Q Report - TradingView
NVA Appoints Ken Burdick Executive Chairman - citybiz
NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO - Stock Titan
LifeStance Health : Q1 2025 Earnings Script - marketscreener.com
LifeStance Health Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1 - Yahoo Finance
LifeStance Health : LFST Q1'25 Earnings Presentation - marketscreener.com
LifeStance Reports First Quarter 2025 Results - The Manila Times
Finanzdaten der Lifestance Health Group Inc-Aktie (LFST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifestance Health Group Inc-Aktie (LFST) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Bessler Robert | Director |
Apr 09 '25 |
Sale |
7.01 |
4,900 |
34,349 |
1,421,990 |
Bessler Robert | Director |
Apr 08 '25 |
Sale |
7.00 |
14 |
98 |
1,424,440 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):